These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 18246050)

  • 21. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
    Murji A; Whitaker L; Chow TL; Sobel ML
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intrauterine progestins, progesterone antagonists, and receptor modulators: a review of gynecologic applications.
    Rodriguez MI; Warden M; Darney PD
    Am J Obstet Gynecol; 2010 May; 202(5):420-8. PubMed ID: 20031112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Selective progesterone receptor modulator (ulipristal acetate--a new option in the pharmacological treatment of uterine fibroids in women].
    Szamatowicz M; Kotarski J
    Ginekol Pol; 2013 Mar; 84(3):219-22. PubMed ID: 23700851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endometrial Changes in Surgical Specimens of Perimenopausal Patients Treated With Ulipristal Acetate for Uterine Leiomyomas.
    Nogales FF; Crespo-Lora V; Cruz-Viruel N; Chamorro-Santos C; Bergeron C
    Int J Gynecol Pathol; 2018 Nov; 37(6):575-580. PubMed ID: 28914672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histomorphological changes in endometriosis in a patient treated with ulipristal: A case report.
    Bateman J; Bougie O; Singh S; Islam S
    Pathol Res Pract; 2017 Jan; 213(1):79-81. PubMed ID: 27914766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis.
    Chwalisz K; Perez MC; Demanno D; Winkel C; Schubert G; Elger W
    Endocr Rev; 2005 May; 26(3):423-38. PubMed ID: 15857972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
    King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
    J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective progesterone receptor modulators.
    Whitaker LH; Williams AR; Critchley HO
    Curr Opin Obstet Gynecol; 2014 Aug; 26(4):237-42. PubMed ID: 24950125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sonographic and hysteroscopic endometrial examination in women treated with ulipristal acetate: Exploratory findings at a tertiary referral center.
    Gracia M; Nonell R; Ros C; Rius M; Quintas L; Martínez-Zamora MÁ; Carmona F
    Eur J Obstet Gynecol Reprod Biol; 2019 Jan; 232():40-45. PubMed ID: 30468982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Interest of selective progesterone receptor modulators in endometriosis].
    Merviel P; Lourdel E; Sanguin S; Gagneur O; Cabry R; Nasreddine A
    Gynecol Obstet Fertil; 2013 Sep; 41(9):524-8. PubMed ID: 23972920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro.
    Jiang J; Wu RF; Wang ZH; Sun HC; Xu Z; Xiu HM
    Fertil Steril; 2002 May; 77(5):995-1000. PubMed ID: 12009357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RU486: pharmacology and potential use in the treatment of endometriosis and leiomyomata uteri.
    Murphy AA; Castellano PZ
    Curr Opin Obstet Gynecol; 1994 Jun; 6(3):269-78. PubMed ID: 8038415
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endometrial histology and biochemistry in climacteric women during oestrogen and oestrogen/progestogen therapy.
    Whitehead MI; King RJ; McQueen J; Campbell S
    J R Soc Med; 1979 May; 72(5):322-7. PubMed ID: 552525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Molecular Changes in Endometrium Associated With Chronic Use of Progesterone Receptor Modulators: Ulipristal Acetate Versus Mifepristone.
    Kannan A; Bhurke A; Sitruk-Ware R; Lalitkumar PG; Gemzell-Danielsson K; Williams ARW; Taylor RN; Bagchi MK; Bagchi IC
    Reprod Sci; 2018 Mar; 25(3):320-328. PubMed ID: 29241443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective progesterone receptor modulators (SPRMs): progesterone receptor action, mode of action on the endometrium and treatment options in gynecological therapies.
    Wagenfeld A; Saunders PT; Whitaker L; Critchley HO
    Expert Opin Ther Targets; 2016 Sep; 20(9):1045-54. PubMed ID: 27138351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis.
    Grandi G; Mueller MD; Papadia A; Kocbek V; Bersinger NA; Petraglia F; Cagnacci A; McKinnon B
    J Reprod Immunol; 2016 Sep; 117():30-8. PubMed ID: 27371899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of progesterone and progestins on endometrial proliferation.
    Moyer DL; Felix JC
    Contraception; 1998 Jun; 57(6):399-403. PubMed ID: 9693400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of levonorgestrel-releasing IUS and progesterone receptor modulator PRM CDB-2914 on uterine leiomyomas.
    Maruo T; Ohara N; Matsuo H; Xu Q; Chen W; Sitruk-Ware R; Johansson ED
    Contraception; 2007 Jun; 75(6 Suppl):S99-103. PubMed ID: 17531625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective progesterone receptor modulators in reproductive medicine: pharmacology, clinical efficacy and safety.
    Bouchard P; Chabbert-Buffet N; Fauser BC
    Fertil Steril; 2011 Nov; 96(5):1175-89. PubMed ID: 21944187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal pathology of the endometrium.
    Deligdisch L
    Mod Pathol; 2000 Mar; 13(3):285-94. PubMed ID: 10757339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.